GENEVA--(BUSINESS WIRE)--Alcon Prices EUR 500 Million Senior Notes Offering.

Netflix Inc. (NASDAQ: NFLX) stock slips as market concerns over third-quarter revenue and earnings g

Alcon reported strong core operating profit (barring a one-time non-cash $402 million charge) during

The famous long-term investor and his team made notable changes to Pershing Square's equity portfoli

Bill Ackman's new stock picks include Netflix, Visa and Mastercard. ETF investors can get fresh

Bill Ackman (Trades, Portfolio)'s Pershing Square Capital Management has built a new position in Net

Bill Ackman (Trades, Portfolio) disclosed six new holdings, buying Netflix (NFLX), Visa (V), Masterc

Bill Ackman’s Pershing Square re-enters Netflix with a 3.15M share stake, declaring the streaming wa

Wall Street analysts made bold moves Thursday, slashing targets on some names while dramatically upg

JP Morgan analyst David Adlington maintains Alcon (NYSE:ALC) with a Neutral and raises the price

Mizuho analyst Anthony Petrone maintains Alcon (NYSE:ALC) with a Outperform and raises the price

U.S. stock futures higher, Nasdaq 100 up 150 pts. National CineMedia shares down 16.4% on weak Q2 re

Alcon Inc. (ALC) Q2 2026 Earnings Call Transcript

Alcon (ALC), a global eye-care powerhouse, raised its 2026 profitability outlook—and investors lik

ALC's Q2 earnings and sales beat estimates as equipment and ocular health gains lift results, while

Swiss-American eye care company Alcon on Monday ​hiked its profit guidance and lowered ‌its estimate

Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quart

Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's af

Alcon (NYSE:ALC) raises FY2026 Adj EPS guidance from $3.38-$3.47 to $3.44-$3.53 vs $3.41 analyst est

Alcon (NYSE:ALC) reported quarterly earnings of $0.84 per share which beat the analyst consensus est

GENEVA--(BUSINESS WIRE)--New Product Launches and Strong Commercial Execution Drive Alcon's Second-Q

GENEVA--(BUSINESS WIRE)--New Product Launches and Strong Commercial Execution Drive Alcon's Second-Q

U.S. stocks closed higher, with Nasdaq up 300 points. S&P 500 and Nasdaq rose for the second con

With U.S. stock futures trading mixed this morning on Monday, some of the stocks that may grab inves

U.S. stock futures mixed, Aecom and Hawaiian Electric report earnings, Alcon expected to release ear

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Alcon (ALC), delve into some

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Investors need to pay close attention to ALC stock based on the movements in the options market late

ST. CATHARINES, Ontario--(BUSINESS WIRE)--Algoma Central Corporation (TSX: ALC) today announced it w

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

GenAI creates new opportunities for ISRG, ALC and LIVN, even as regulatory, inflation and industry h

Mizuho analyst Anthony Petrone maintains Alcon (NYSE:ALC) with a Outperform and lowers the price

Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxS

Weak earnings, soft guidance and analyst target cuts triggered sharp selloffs across healthcare, sof

Barclays analyst Matt Miksic maintains Alcon (NYSE:ALC) with a Equal-Weight and lowers the price

Wells Fargo analyst Larry Biegelsen maintains Alcon (NYSE:ALC) with a Overweight and lowers the p

Mizuho analyst Anthony Petrone maintains Alcon (NYSE:ALC) with a Outperform and lowers the price

Baird analyst Jeff Johnson maintains Alcon (NYSE:ALC) with a Outperform and lowers the price targ

Alcon (NYSE:ALC) raises FY2026 Adj EPS guidance from $3.35-$3.44 to $3.38-$3.47 vs $3.38 analyst est

Alcon (NYSE:ALC) reported quarterly earnings of $0.85 per share which beat the analyst consensus est

Alcon cancels $356 million LENSAR merger due to regulatory delays and FTC opposition, adding pressur

LENSAR, Inc. (NASDAQ:LNSR) ("LENSAR" or the "Company"), a global medical technology

Barclays analyst Matt Miksic maintains Alcon (NYSE:ALC) with a Equal-Weight and raises the price